These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8040309)

  • 1. Substitution of arginine-839 by cysteine or histidine in the androgen receptor causes different receptor phenotypes in cultured cells and coordinate degrees of clinical androgen resistance.
    Beitel LK; Kazemi-Esfarjani P; Kaufman M; Lumbroso R; DiGeorge AM; Killinger DW; Trifiro MA; Pinsky L
    J Clin Invest; 1994 Aug; 94(2):546-54. PubMed ID: 8040309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human androgen insensitivity due to point mutations encoding amino acid substitutions in the androgen receptor steroid-binding domain.
    Murono K; Mendonca BB; Arnhold IJ; Rigon AC; Migeon CJ; Brown TR
    Hum Mutat; 1995; 6(2):152-62. PubMed ID: 7581399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A point mutation in the second zinc finger of the DNA-binding domain of the androgen receptor gene causes complete androgen insensitivity in two siblings with receptor-positive androgen resistance.
    Mowszowicz I; Lee HJ; Chen HT; Mestayer C; Portois MC; Cabrol S; Mauvais-Jarvis P; Chang C
    Mol Endocrinol; 1993 Jul; 7(7):861-9. PubMed ID: 8413310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitution of valine-865 by methionine or leucine in the human androgen receptor causes complete or partial androgen insensitivity, respectively with distinct androgen receptor phenotypes.
    Kazemi-Esfarjani P; Beitel LK; Trifiro M; Kaufman M; Rennie P; Sheppard P; Matusik R; Pinsky L
    Mol Endocrinol; 1993 Jan; 7(1):37-46. PubMed ID: 8446106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amber mutation creates a diagnostic MaeI site in the androgen receptor gene of a family with complete androgen insensitivity.
    Trifiro M; Prior RL; Sabbaghian N; Pinsky L; Kaufman M; Nylen EG; Belsham DD; Greenberg CR; Wrogemann K
    Am J Med Genet; 1991 Sep; 40(4):493-9. PubMed ID: 1720929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the molecular consequences of different mutations at residue 754 and 690 of the androgen receptor (AR) and androgen insensitivity syndrome (AIS) phenotype.
    Tadokoro R; Bunch T; Schwabe JW; Hughes IA; Murphy JC
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):253-60. PubMed ID: 19178528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.
    Culig Z; Stober J; Gast A; Peterziel H; Hobisch A; Radmayr C; Hittmair A; Bartsch G; Cato AC; Klocker H
    Cancer Detect Prev; 1996; 20(1):68-75. PubMed ID: 8907206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of androgen-resistant subjects indicates that the 6.7 pI/56 kDa protein in genital skin fibroblasts is related to the androgen receptor.
    Nickel B; Schwartz A; Rosenmann E; Kaufman M; Pinsky L; Wrogemann K
    Clin Invest Med; 1988 Feb; 11(1):22-33. PubMed ID: 3259169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Familial form of partial androgen insensitivity (Reifenstein syndrome): arginine-histidine mutation in position 840 in the androgen receptor].
    Lumbroso S; Lobaccaro JM; Belon C; Amram S; Rodier M; Bringer J; Sultan C
    C R Seances Soc Biol Fil; 1993; 187(4):508-15. PubMed ID: 8019921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting phenotypic variation among AIS patients.
    Wang M; Wang J; Zhang Z; Zhao Z; Zhang R; Hu X; Tan T; Luo S; Luo Z
    Biochem Biophys Res Commun; 2005 Sep; 335(2):335-42. PubMed ID: 16083860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial androgen resistance due to a distinctive qualitative defect of the androgen receptor.
    Pinsky L; Kaufman M; Levitsky LL
    Am J Med Genet; 1987 Jun; 27(2):459-66. PubMed ID: 3605226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions.
    Ghadessy FJ; Lim J; Abdullah AA; Panet-Raymond V; Choo CK; Lumbroso R; Tut TG; Gottlieb B; Pinsky L; Trifiro MA; Yong EL
    J Clin Invest; 1999 Jun; 103(11):1517-25. PubMed ID: 10359561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An androgen receptor mutation causing androgen resistance in undervirilized male syndrome.
    Tsukada T; Inoue M; Tachibana S; Nakai Y; Takebe H
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1202-7. PubMed ID: 7962294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction.
    Quigley CA; Tan JA; He B; Zhou ZX; Mebarki F; Morel Y; Forest MG; Chatelain P; Ritzén EM; French FS; Wilson EM
    Mech Ageing Dev; 2004; 125(10-11):683-95. PubMed ID: 15541764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly-->Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels.
    Choong CS; Sturm MJ; Strophair JA; McCulloch RK; Tilley WD; Leedman PJ; Hurley DM
    J Clin Endocrinol Metab; 1996 Jan; 81(1):236-43. PubMed ID: 8550758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen resistance associated with a mutation of the androgen receptor at amino acid 772 (Arg----Cys) results from a combination of decreased messenger ribonucleic acid levels and impairment of receptor function.
    Marcelli M; Tilley WD; Zoppi S; Griffin JE; Wilson JD; McPhaul MJ
    J Clin Endocrinol Metab; 1991 Aug; 73(2):318-25. PubMed ID: 1856263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacement of arginine 773 by cysteine or histidine in the human androgen receptor causes complete androgen insensitivity with different receptor phenotypes.
    Prior L; Bordet S; Trifiro MA; Mhatre A; Kaufman M; Pinsky L; Wrogeman K; Belsham DD; Pereira F; Greenberg C
    Am J Hum Genet; 1992 Jul; 51(1):143-55. PubMed ID: 1609793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A naturally occurring mutation in the human androgen receptor of a subject with complete androgen insensitivity confers binding and transactivation by estradiol.
    Bonagura TW; Deng M; Brown TR
    Mol Cell Endocrinol; 2007 Jan; 263(1-2):79-89. PubMed ID: 17011702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-radioactive SSCP for the detection of androgen receptor gene mutation--a diagnostic tool for androgen resistance].
    Hiort O; Wodtke A; Struve D; Sinnecker GH
    Verh Dtsch Ges Pathol; 1994; 78():200-3. PubMed ID: 7533986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor point mutations as the underlying molecular defect in 2 patients with androgen insensitivity syndrome.
    Radmayr C; Culig Z; Glatzl J; Neuschmid-Kaspar F; Bartsch G; Klocker H
    J Urol; 1997 Oct; 158(4):1553-6. PubMed ID: 9302173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.